MetLife (MET) Misses Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts MET Hot Sheet
Price: $95.74 -1.93%
Revenue Growth %: +15.8%
Financial Fact:
Total net investment gains (losses): 257M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Total net investment gains (losses): 257M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q3 EPS of $0.62, $0.14 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $18 billion versus the consensus estimate of $17.72 billion.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- GE Aerospace to acquire Consolidated Precision in $11.75b deal
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
